by Cort Johnson | Aug 2, 2025 | Bezisterim , Brain , Cognition , Homepage , Immune , Inflammation , Neuroinflammation
The new Bezisterin long COVID trials seeks to tamp down inflammation at the source and improve cognitive and fatigue.
by Cort Johnson | Jul 18, 2025 | B-cells , Drugs , Homepage , Immune , Inflammation , Interferons , Monoclonal antibodies , Natural Killer Cells , Treatment
A B-cell depleter called daratumumab does well in an early trial in ME/CFS. A larger trial is underway.
by Cort Johnson | Jun 15, 2025 | Astrocytes , Connective Tissues , Craniocervical Instability , Cytokines , Fibromyalgia and Pain , Homepage , Inflammation , Matrix metalloproteinases , Monocytes , Neuroinflammation , Neuroinflammation , Research
A cerebral spinal fluid study finds a cluster of ME/CFS patients who may have spinal issues including craniocervical instability.
by Cort Johnson | Jun 11, 2025 | Baritcinib , COVID-19 , Cytokines , Drugs , Gut , Homepage , Immune , Inflammation , long COVID , Metformin , Microbiome , Monocytes , Oxidative Stress , Rapamycin , Research , T-cells , Treatment
Profound immune dysregulation could be the tipping point that turns a COVID-19 patient into a long COVID patient.
by Cort Johnson | May 28, 2025 | GLP-1 , Homepage , Inflammation , Kaufman , long COVID , Mast cell activation syndrome , Mast cell activation syndrome , Metabolism , Microbiome , Neuroinflammation , Ruhoy
GLP-1 agonists like Ozempic could be surprisingly helpful in diseases like chronic fatigue syndrome, fibromyalgia and long COVID.
by Cort Johnson | Mar 13, 2025 | B-cells , Clotting , COVID-19 , Homepage , Immune , Inflammation , Lipids , Pathogens , Plasmapheresis , Research , Treatment
Check out how blood cleansing techniques to remove pathogenic factors in chronic fatigue syndrome (ME/CFS) and long COVID may (or may not) be helping in these diseases.